Management Dispute Resolved: Court Recommends Settlement, Directors Resign
- The lawsuit for removal of directors at Dongseong Pharmaceutical (Case No. 2025가합20903) has been concluded via a court-recommended settlement.
- Under the settlement, two defendant directors (N and W) resigned from their positions, and the plaintiff (Brand Refactoring Co.) abandoned the remaining claims.
- Each party bears its own litigation costs.
- Decision date: April 24, 2026; Confirmation date: May 14, 2026 (no objection filed).
- This follows the initial disclosure of the management dispute lawsuit on Oct 30, 2025; the resolution removes legal uncertainty.
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Judgment/Decision on Litigation, etc.
- Company: Dongsung Pharmaceutical (002210)
- Submission: Dongsung Pharmaceutical Co., Ltd.
- Receipt: 05-14-2026
- Under KRX KOSPI Market Division